By allowing companies to claim a 50% tax credit for qualified clinical testing expenses, developing drugs for rare diseases became economically feasible for the first time.
There was so much bigger-picture coverage of pharma and healthcare in 2017 – pricing, Affordable Care Act reform and repeal – that it was easy to lose sight of everything else. PwC’s Health Research Institute has used its annual look-ahead report to spotlight a handful of undercover trends.
How should pharma mine electronic health records as a data source?
At a time when value-based healthcare is a more common objective among stakeholders, EHR data can enable collaboration among payers, providers, health systems, and pharma manufacturers.
10 myths about millennials and their healthcare habits
More has been written about millennials — and their healthcare habits — than about any other generation. Here, Gen Y marketers explain why most of what you’ve read is wrong.
2018 MAHF: Leverte ‘was as good with clients as anyone you’ve ever seen’
Zero people have such tales about Robert Leverte, which is why news of his pending induction into the Medical Advertising Hall of Fame was received warmly when it was made public last October.
Big Predictions: Agency gurus on the future of data in the industry
We asked some of the agency world’s sharpest data people to answer a pair of questions about the future of data in and around pharma marketing. Here’s what they had to say.
High five: How these companies are leveraging data to engage A-list HCPs